VAERS reports by lot

GSK Varicella/Shingles lot JE45P: VAERS reports

29 VAERS reports list lot JE45P as a GSK Varicella/Shingles vaccine, received between 2019-02-07 and 2019-06-08. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
29
Reports
7%
Marked serious
0
With a death outcome
5
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)3429%
Injection-site / Local reaction1815%
Musculoskeletal1614%
Dermatological (non-injection-site)1513%
Cardiac / Cardiovascular119%
Gastrointestinal98%
Neurological76%
Allergic / Anaphylactic65%
Autoimmune / Immune-mediated11%
Respiratory11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Texas5
California5
Washington3
Ohio2
Iowa2
Colorado2
Tennessee1
Mississippi1
Oklahoma1
North Carolina1
Nevada1
South Dakota1

Reports by month received

2019-028
2019-039
2019-043
2019-055
2019-064

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.